Below are the most recent publications written about "Diabetes Mellitus, Type 1" by people in Profiles.
-
Lu CC, Chang CH, Chou JC, Yu PL, Wang PS. Regulatory mechanism of ghrelin on testosterone secretion in type 1 diabetic rats. Reprod Fertil. 2025 Jul 01; 6(3).
-
Jeddi S, Kashfi K, Ghasemi A. The potential role of nitrate, a nitric oxide donor, in the prevention and treatment of diabetic osteoporosis. Front Endocrinol (Lausanne). 2025; 16:1480838.
-
Sobhani NC, Huang Y, Venkatesh KK, Wright JD, Friedman AM, Wen T. Diabetes Technology Use in Pregnancies with Type 1 Diabetes in the United States from 2009 to 2020. Am J Perinatol. 2026 Mar; 43(4):453-460.
-
Shao H, Thorpe LE, Islam S, Bian J, Guo Y, Li P, Bost S, Dabelea D, Conway R, Crume T, Schwartz BS, Hirsch AG, Allen KS, Dixon BE, Grannis SJ, Lustigova E, Reynolds K, Rosenman M, Zhong VW, Wong A, Rivera P, Le T, Akerman M, Conderino S, Rajan A, Liese AD, Rudisill C, Obeid JS, Ewing JA, Bailey C, Mendonca EA, Zaganjor I, Rolka D, Imperatore G, Pavkov ME, Divers J. Developing a Computable Phenotype for Identifying Children, Adolescents, and Young Adults With Diabetes Using Electronic Health Records in the DiCAYA Network. Diabetes Care. 2025 Jun 01; 48(6):914-921.
-
Nicholas CA, Tensun FA, Evans SA, Toole KP, Prendergast JE, Broncucia H, Hesselberth JR, Gottlieb PA, Wells KL, Smith MJ. Activated polyreactive B cells are clonally expanded in autoantibody positive and patients with recent-onset type 1 diabetes. Cell Rep. 2025 Apr 22; 44(4):115425.
-
Vaishnav MS, Kumari N, Srikanta S, Simha V, Krishnaswamy PR, Bhat N. Truncated Albumins as Novel Surrogate Biomarkers in Diabetes Therapy: Epiphenomena and Potential Clinical Applications. Metab Syndr Relat Disord. 2024 Dec; 22(10):743-752.
-
Davidson MB, Davidson SJ. Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians. Diabetes Obes Metab. 2024 Aug; 26(8):3475-3477.
-
Darshi M, Kugathasan L, Maity S, Sridhar VS, Fernandez R, Limonte CP, Grajeda BI, Saliba A, Zhang G, Drel VR, Kim JJ, Montellano R, Tumova J, Montemayor D, Wang Z, Liu JJ, Wang J, Perkins BA, Lytvyn Y, Natarajan L, Lim SC, Feldman H, Toto R, Sedor JR, Patel J, Waikar SS, Brown J, Osman Y, He J, Chen J, Reeves WB, de Boer IH, Roy S, Vallon V, Hallan S, Gelfond JA, Cherney DZ, Sharma K. Glycolytic lactate in diabetic kidney disease. JCI Insight. 2024 Jun 10; 9(11).
-
Hixon JC, Rivas Zarete JI, White J, Hilaire M, Muhammad A, Yusuf AP, Adu-Addai B, Yates CC, Mahavadi S. Epigenetic Modulation of GPER Expression in Gastric and Colonic Smooth Muscle of Male and Female Non-Obese Diabetic (NOD) Mice: Insights into H3K4me3 and H3K27ac Modifications. Int J Mol Sci. 2024 May 11; 25(10).
-
Vaishnav MS, Kumari N, Srikanta S, Simha V, Krishnaswamy PR, Balaram P, Bhat N. Albumin Oxidation and Albumin Glycation Discordance During Type 2 Diabetes Therapy: Biological and Clinical Implications. Metab Syndr Relat Disord. 2024 Jun; 22(5):372-384.